<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-111590</identifier>
<setSpec>0001-7310</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">New Developments in Erythropoietic Porphyrias</dc:title>
<dc:description xml:lang="en">In recent years, important advances have been made in our understanding of the genetics of porphyrias, particularly with respect to erythropoietic protoporphyria (EPP) and congenital erythropoietic porphyria (CEP), 2 forms of erythropoietic porphyria no longer considered to be monogenic. The identification of mutations in genes not previously associated with these disorders as causative factors or modulators of severity has helped to explain the presence of genotypic and phenotypic differences between patients carrying the same mutations. These advances have also led to the identification of causative genetic defects in patients who, based on molecular studies, had no mutations in the uroporphyrinogen III synthase gene UROS (in CEP) or in the ferrochelatase gene FECH (in EPP). Better understanding and characterization of the genetics of porphyrias will allow us to determine genotypic and phenotypic correlations and improve the molecular classification of these diseases, which will have both practical and prognostic implications (AU)</dc:description>
<dc:creator>Herrero, C</dc:creator>
<dc:creator>Darwich, E</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">En los últimos años se han producido importantes avances en la genética de las porfirias y, concretamente, en las porfirias eritropoyéticas &#151;protoporfiria eritropoyética (PPE) y porfiria eritropoyética congénita (PEC)&#151;, que han dado lugar a una nueva concepción de las mismas como enfermedades no monogénicas. Se han identificado mutaciones en nuevos genes como responsables o modificadores de la gravedad de la porfiria, permitiendo esclarecer las discrepancias geno-fenotípicas observadas entre pacientes portadores de las mismas mutaciones, así como identificar el defecto genético responsable de algunos casos de porfiria en los que los estudios moleculares del gen uroporfirinógeno sintetasa (UROS) en la PEC o del gen ferroquelatasa (FECH) en la PPE no identificaban ninguna mutación. La mejor caracterización y conocimiento de la genética de estas enfermedades permitirá establecer cuadros geno-fenotípicos concretos y realizar una clasificación molecular con implicaciones prácticas y pronósticas (AU)</dc:description>
<dc:source>Actas Dermosifiliogr;104(3): 212-219, abr. 2013. ilus</dc:source>
<dc:identifier>ibc-111590</dc:identifier>
<dc:title xml:lang="es">Novedades en las porfirias eritropoyéticas</dc:title>
<dc:subject>^d4555^s22032</dc:subject>
<dc:subject>^d38626^s22080</dc:subject>
<dc:subject>^d4555^s22012</dc:subject>
<dc:subject>^d38626^s22032</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d11606^s22080</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d30606^s22080</dc:subject>
<dc:subject>^d38626^s22033</dc:subject>
<dc:subject>^d38626^s22027</dc:subject>
<dc:subject>^d4977^s22012</dc:subject>
<dc:subject>^d11606^s22033</dc:subject>
<dc:subject>^d4977^s22016</dc:subject>
<dc:subject>^d30606^s22033</dc:subject>
<dc:type>article</dc:type>
<dc:date>201304</dc:date>
</metadata>
</record>
</ibecs-document>
